✉news BusinessFinance first seen 14 h ago, last 5 h ago, peak #2
Spyre Therapeutics stock draws investor attention
Original: Spyre Therapeutics, Inc. (SYRE) stock price, news, quote and history
Spyre Therapeutics, Inc. (SYRE) is drawing attention from investors tracking its stock price, news, quotes and trading history. The clinical-stage biotech, which develops treatments for inflammatory bowel disease, is being closely watched as traders look up its latest market performance and company updates.
Why now: Investors are actively checking the stock's price and latest news, suggesting recent market movement or company developments.
Rank over time, top of the chart is #1. 8 snapshots from 14 h ago to 5 h ago.
Evidence
- Spyre Therapeutics, Inc. (SYRE) stock price, news, quote and history · Yahoo Finance UK
API: https://socialmediatrends-api.osmike.com/v1/trends/892319